(Q40215655)

English

Troglitazone and pioglitazone interactions via PPAR-gamma-independent and -dependent pathways in regulating physiological responses in renal tubule-derived cell lines

scientific article published on 25 October 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Troglitazone and pioglitazone interactions via PPAR-gamma-independent and -dependent pathways in regulating physiological responses in renal tubule-derived cell lines (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

author name string

Francesco Turturro

1

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Robert Oliver

2

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Ellen Friday

3

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Itzhak Nissim

4

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Tomas Welbourne

5

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

publication date

25 October 2006

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

American Journal of Physiology - Cell Physiology

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

292

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

C1137-46

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

New pharmacological perspectives and therapeutic potential of PPAR-gamma agonists

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00396.2006

21 January 2018

Ligand-independent activation of peroxisome proliferator-activated receptor-gamma by insulin and C-peptide in kidney proximal tubular cells: dependent on phosphatidylinositol 3-kinase activity

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00396.2006

21 January 2018

Quantitative characteristics of glutamate transport in rat liver mitochondria

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00396.2006

21 January 2018

Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions?

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00396.2006

21 January 2018

Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00396.2006

21 January 2018

Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00396.2006

21 January 2018

Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00396.2006

21 January 2018

Glitazones regulate glutamine metabolism by inducing a cellular acidosis in MDCK cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00396.2006

21 January 2018

Peroxisome proliferator-activated receptor gamma thiazolidinedione agonists increase glucose metabolism in astrocytes

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00396.2006

21 January 2018

Phosphorylation of PPARs: from molecular characterization to physiological relevance

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00396.2006

21 January 2018

Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key?

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00396.2006

21 January 2018

Troglitazone and related compounds: therapeutic potential beyond diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00396.2006

21 January 2018

Acute non-insulin-like stimulation of rat muscle glucose metabolism by troglitazone in vitro

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00396.2006

21 January 2018

Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00396.2006

21 January 2018

The intensity of acidosis differentially alters the pathways of ammoniagenesis in LLC-PK1 cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00396.2006

21 January 2018

Troglitazone's rapid and sustained activation of ERK1/2 induces cellular acidosis in LLC-PK1-F+ cells: physiological responses

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00396.2006

21 January 2018

Glitazones differentially regulate primary astrocyte and glioma cell survival. Involvement of reactive oxygen species and peroxisome proliferator-activated receptor-gamma.

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00396.2006

21 January 2018

Peroxisome proliferator-activated receptor γ in diabetes and metabolism

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00396.2006

21 January 2018

Mitochondrial respiratory chain dysfunction, a non-receptor-mediated effect of synthetic PPAR-ligands: biochemical and pharmacological implications

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00396.2006

21 January 2018

15-Deoxy-delta 12,14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00396.2006

21 January 2018

Role of c-SRC and ERK in acid-induced activation of NHE3

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00396.2006

21 January 2018

Troglitazone acts on cellular pH and DNA synthesis through a peroxisome proliferator-activated receptor gamma-independent mechanism in breast cancer-derived cell lines

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00396.2006

21 January 2018

Troglitazone acts by PPARγ and PPARγ-independent pathways on LLC-PK1-F+acid-base metabolism

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00396.2006

21 January 2018

Troglitazone induces a cellular acidosis by inhibiting acid extrusion in cultured rat mesangial cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00396.2006

21 January 2018

Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts.

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00396.2006

21 January 2018

Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00396.2006

21 January 2018

Identifiers

10.1152/AJPCELL.00396.2006

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40215655&oldid=1888774228"